
Coagulation Factor Concentrates Market by Type of Coagulation Factor (Factor IX (FIX) concentrates, Factor VII (FVII) concentrates, Factor VIII (FVIII) concentrates), Product Formulation (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagula
Description
Coagulation Factor Concentrates Market by Type of Coagulation Factor (Factor IX (FIX) concentrates, Factor VII (FVII) concentrates, Factor VIII (FVIII) concentrates), Product Formulation (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates), Application, End-User - Global Forecast 2024-2030
The Coagulation Factor Concentrates Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 8.84 billion in 2024, at a CAGR 7.46% to reach USD 14.34 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Factor Concentrates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Factor Concentrates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Coagulation Factor Concentrates Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bio Products Laboratory Limited, BIOGEN INC., Biotest AG., Cerus Corporation, Emergent BioSolutions Inc., Kedrion S.p.A, LFB USA, Medscape Network, Novo Nordisk A/S, Octapharma USA, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Coagulation Factor Concentrates Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type of Coagulation Factor
Factor IX (FIX) concentrates
Factor VII (FVII) concentrates
Factor VIII (FVIII) concentrates
Factor XIII (FXIII) concentrates
Product Formulation
Plasma-Derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Application
Hemophilia Treatment
Surgical Procedures
End-User
Homecare Settings
Hospitals
Specialty Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Coagulation Factor Concentrates Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Factor Concentrates Market?
3. What are the technology trends and regulatory frameworks in the Coagulation Factor Concentrates Market?
4. What is the market share of the leading vendors in the Coagulation Factor Concentrates Market?
5. Which modes and strategic moves are suitable for entering the Coagulation Factor Concentrates Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Coagulation Factor Concentrates Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of hemophilia and clotting deficiencies
- 5.1.1.2. Increase in biotechnology R&D to develop effective coagulation factor concentrates
- 5.1.1.3. Inclination toward early diagnosis and treatment of diseases
- 5.1.2. Restraints
- 5.1.2.1. Contamination issues associated with the synthesis of coagulation factor concentrate
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of improved coagulation factor concentrates
- 5.1.3.2. Significant advancements in gene therapy
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulatory procedure for product approval
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Coagulation Factor Concentrates Market, by Type of Coagulation Factor
- 6.1. Introduction
- 6.2. Factor IX (FIX) concentrates
- 6.3. Factor VII (FVII) concentrates
- 6.4. Factor VIII (FVIII) concentrates
- 6.5. Factor XIII (FXIII) concentrates
- 7. Coagulation Factor Concentrates Market, by Product Formulation
- 7.1. Introduction
- 7.2. Plasma-Derived Coagulation Factor Concentrates
- 7.3. Recombinant Coagulation Factor Concentrates
- 8. Coagulation Factor Concentrates Market, by Application
- 8.1. Introduction
- 8.2. Hemophilia Treatment
- 8.3. Surgical Procedures
- 9. Coagulation Factor Concentrates Market, by End-User
- 9.1. Introduction
- 9.2. Homecare Settings
- 9.3. Hospitals
- 9.4. Specialty Clinics
- 10. Americas Coagulation Factor Concentrates Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Coagulation Factor Concentrates Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Coagulation Factor Concentrates Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Bayer AG
- 14.1.2. Bio Products Laboratory Limited
- 14.1.3. BIOGEN INC.
- 14.1.4. Biotest AG.
- 14.1.5. Cerus Corporation
- 14.1.6. Emergent BioSolutions Inc.
- 14.1.7. Kedrion S.p.A
- 14.1.8. LFB USA
- 14.1.9. Medscape Network
- 14.1.10. Novo Nordisk A/S
- 14.1.11. Octapharma USA, Inc.
- 14.1.12. Pfizer Inc.
- 14.1.13. Takeda Pharmaceutical Company Limited
- 14.1.14. Thermo Fisher Scientific Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. COAGULATION FACTOR CONCENTRATES MARKET RESEARCH PROCESS
- FIGURE 2. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2023 VS 2030
- FIGURE 3. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. COAGULATION FACTOR CONCENTRATES MARKET DYNAMICS
- FIGURE 7. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2030 (%)
- FIGURE 8. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2030 (%)
- FIGURE 10. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.